Literature DB >> 12715002

Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.

Ho Min Kim1, Kyung Sook Yu, Mi Eun Lee, Dong Ryeol Shin, Young Sang Kim, Sang-Gi Paik, Ook Joon Yoo, Hayyoung Lee, Jie-Oh Lee.   

Abstract

B-cell activating factor (BAFF) is a key regulator of B-lymphocyte development. Its biological role is mediated by the specific receptors BCMA, TACI and BAFF-R. We have determined the crystal structure of the extracellular domain of BAFF-R bound to BAFF at a resolution of 3.3 A. The cysteine-rich domain (CRD) of the BAFF-R extracellular domain adopts a beta-hairpin structure and binds to the virus-like BAFF cage in a 1:1 molar ratio. The conserved DxL motif of BAFF-R is located on the tip of the beta-turn and is indispensable in the binding of BAFF. The crystal structure shows that a unique dimeric contact occurs between the BAFF-R monomers in the virus-like cage complex. The extracellular domain of TACI contains two CRDs, both of which contain the DxL motif. Modeling of TACI-BAFF complex suggests that both CDRs simultaneously interact with the BAFF dimer in the virus-like cage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12715002     DOI: 10.1038/nsb925

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  20 in total

Review 1.  Identification of structural domains involved in astrovirus capsid biology.

Authors:  Neel K Krishna
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

2.  Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation.

Authors:  Hyun-Jung An; Young Jin Kim; Dong Hyun Song; Beom Suk Park; Ho Min Kim; Ju Dong Lee; Sang-Gi Paik; Jie-Oh Lee; Hayyoung Lee
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

Review 3.  Synthetic multivalent ligands as probes of signal transduction.

Authors:  Laura L Kiessling; Jason E Gestwicki; Laura E Strong
Journal:  Angew Chem Int Ed Engl       Date:  2006-04-03       Impact factor: 15.336

Review 4.  Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

Review 5.  TNF superfamily protein-protein interactions: feasibility of small- molecule modulation.

Authors:  Yun Song; Peter Buchwald
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

6.  Decoy strategies: the structure of TL1A:DcR3 complex.

Authors:  Chenyang Zhan; Yury Patskovsky; Qingrong Yan; Zhenhong Li; Udupi Ramagopal; Huiyong Cheng; Michael Brenowitz; Xiao Hui; Stanley G Nathenson; Steven C Almo
Journal:  Structure       Date:  2011-02-09       Impact factor: 5.006

7.  Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).

Authors:  Lilit Garibyan; Adrian A Lobito; Richard M Siegel; Matthew E Call; Kai W Wucherpfennig; Raif S Geha
Journal:  J Clin Invest       Date:  2007-05-10       Impact factor: 14.808

8.  The design and characterization of receptor-selective APRIL variants.

Authors:  Fiona C Kimberley; Almer M van der Sloot; Marco Guadagnoli; Katherine Cameron; Pascal Schneider; J Arnoud Marquart; Miranda Versloot; Luis Serrano; Jan Paul Medema
Journal:  J Biol Chem       Date:  2012-09-07       Impact factor: 5.157

9.  TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.

Authors:  Sharron A N Brown; Heather N Hanscom; Hong Vu; Shelesa A Brew; Jeffrey A Winkles
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

10.  Solution structure of the cysteine-rich domain in Fn14, a member of the tumor necrosis factor receptor superfamily.

Authors:  Fahu He; Weirong Dang; Kohei Saito; Satoru Watanabe; Naohiro Kobayashi; Peter Güntert; Takanori Kigawa; Akiko Tanaka; Yutaka Muto; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.